During the past decade, University of South Carolina School of Medicine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of South Carolina School of Medicine" #1 sponsor was "Bristol-Myers Squibb" with 4 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Roswell Park Cancer Institute" with 2 trials sponsored, "Aeris Therapeutics" with 1 trials sponsored and "BHR Pharma, LLC" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of South Carolina School of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cystic Fibrosis Foundation" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator and "Glaxo Wellcome" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "University of South Carolina School of Medicine" are "HIV Infections" (5 trials), "Leukemia" (4 trials), "Myelodysplastic Syndromes" (4 trials), "Lymphoma" (3 trials) and "Graft Versus Host Disease" (2 trials). Many other conditions were trialed in "University of South Carolina School of Medicine" in a lesser frequency.

Most popular intervention types in "University of South Carolina School of Medicine" are "Drug" (20 trials), "Biological" (4 trials), "Procedure" (4 trials), "Radiation" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclosporine" (4 trials), "radiation therapy" (4 trials), "cyclophosphamide" (3 trials), "methylprednisolone" (3 trials) and "Atazanavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of South Carolina School of Medicine" are 21 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of South Carolina School of Medicine". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in University of South Carolina School of Medicine, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of South Carolina School of Medicine, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".